Navigation Links
Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
Date:10/29/2010

;Auxilium also has options to all indications using XIAFLEX for non-topical formulations.  For additional information, visit http://www.auxilium.com.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intention to present at the 2010 Citi Annual Global Healthcare Conference; and products in development for Peyronie's disease, Frozen Shoulder syndrome, overactive bladder, pain, hormone replacement and urologic disease; and all other statements containing projections, statements of future performance or expectations, our beliefs or statements of plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Forward-looking statements can generally be identified by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium's Annual Report under the heading "Risk Factors" on Form 10-K for the year ended December 31, 2009 and in Auxilium's Quarterly Report on Form 10-Q for the quarte
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
2. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Jazz Pharmaceuticals Announces November 4 Conference Call to Discuss Third Quarter 2010 Results and Guidance
7. Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010
8. Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010
9. Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist
10. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
11. Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals Antibody Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... Mass. and JERUSALEM, Israel, Aug. 31, 2015 /PRNewswire/ ... late-stage biopharmaceutical company developing octreotide capsules for the ... the second quarter ended June 30, 2015 and ... few months have been a transformative time for ... offering and recently announced that our first New ...
(Date:8/31/2015)... Thousands of people will peacefully demonstrate their frustration with ... at dozens of rallies across the country today. Since ... United States has experienced skyrocketing rates of ... yet the President has never once spoken publicly about ... President Obama , rally organizers compared his failure to ...
Breaking Medicine Technology:DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
... Reportlinker.com announces that a new ... its catalogue: A ... Lymphoma Pipeline: From Research and Development ... http://www.reportlinker.com/p0507256/A-Decision-Support-Tool-for-Optimizing-The-Lymphoma-Pipeline-From-Research-and-Development-to-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology This ...
... Calif., May 23, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... that management will present a general corporate update in conjunction ... on Thursday, June 16 at 2:15 p.m. Pacific Time in ... p.m. – 2:15 p.m. Annual Meeting of Stockholders (only for ...
Cached Medicine Technology:Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 2Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 3Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 4Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 5Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 6Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 7Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 8Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 9Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 10Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 11Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 12Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 13Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 14Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 15Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 16Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 17Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 18Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market 19Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... a top-five hospital by U.S. News & World Report, to provide breaking news ... , Editorial and marketing groups within OncLive, which provides oncologists resources and information?they ...
(Date:9/1/2015)... , ... September 01, 2015 , ... The Jerry Segal ... The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over the ... more than $13.5 million for programs and services designed to support patients and their ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding members, Inmar ... inception more than 35 years ago. A pilot program begun by the company in ... not just those intent on pursuing careers in these fields. The program is now ...
(Date:9/1/2015)... ... 2015 , ... e-Spirit Inc., a leading supplier of content ... Management System with new capabilities and enhancements designed to support the recently announced ... well on their way to achieving digital transformation with less time and less ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data ... new version of endpoint DLP developed specifically for Mac OS. , In June 2015, ... 100 IT and information security professionals had participated. The beta test done by the ...
Breaking Medicine News(10 mins):Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:Zecurion Announces Endpoint Security for Mac 2
... the death of an 11-year-old boy yesterday of H5N1 bird ... bird flu in Indonesia to 53 and cases of infection, ... Jakarta who was reported to have had contact with infected ... symptoms; last Thursday, and died Saturday evening. ,In Indonesia ...
... at the University of Montana has revealed that methamphetamine, when ... upto 80-90%. It was used initially to aggravate stroke symptoms ... surprising and was repeated in further attempts. ,The research ... of the brain responsible for learning functions. They were kept ...
... called Rosiglitazone capable of controlling Type 2 diabetes has been ... drug is capable of reported in The Lancet ,a ... is capable of reducing Type 2 Diabetes by 60%. ... named DREAM(for Diabetes Reduction Approaches with Medication )conducted at Royal ...
... more likely to visit their GP as they age ... may not mention //their reproductive health problems. ,So say ... Medical Journal of Australia. ,Dr Carol Holden, CEO ... study into middle-aged and older Australian men’s help-seeking behaviour ...
... awareness class for sex workers in China had angered the ... a group of over 50 sex workers by the Center ... the Beijing News. It reported that the local police found ... prostitutes labeled their profession on their foreheads this time. Being ...
... for Organ Transplantation had its annual meet, ISOT 2006 ... from across the country got together to deliberate on ... transplantation in the country. With cadaveric organ donation being ... the public and the medical fraternity was highlighted as ...
Cached Medicine News:Health News:New drug proven to tackle Type 2 Diabetes 2Health News:Men Shun Reproductive Health Help 2Health News:Indian Doctors Agree to Promote Cadaveric Organ Transplantation 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: